Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hulthe

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Metabolism: Clinical and Experimental|February 15, 2001
Low-density lipoprotein particle size, insulin resistance, and proinsulin in a population sample of 58-year-old menB Fagerberg, J Hulthe, L Bokemark, et al.
Journal of Internal Medicine|October 16, 2004
Oxidized low-density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy menK Wallenfeldt, B Fagerberg, J Wikstrand, et al.
Atherosclerosis|December 31, 2005
apoB/apoA-I ratio is related to femoral artery plaques and is predictive for future cardiovascular events in healthy menC Schmidt, B Fagerberg, J Wikstrand, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 9, 2000
The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) studyJ Hulthe, L Bokemark, J Wikstrand, et al.
Journal of Internal Medicine|March 26, 2003
Multiple risk factor intervention reduces cardiovascular risk in hypertensive patients with echolucent plaques in the carotid arteryC Schmidt, B Fagerberg, J Wikstrand, et al.
Journal of Internal Medicine|May 15, 2001
Cell adhesion molecules and secretory type II phospholipase A2 in relation to carotid atherosclerosis in patients with hypercholesterolaemiaO Wiklund, J Hulthe, G Bondjers, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 7, 2001
Antibodies to oxidized LDL in relation to carotid atherosclerosis, cell adhesion molecules, and phospholipase A(2)J Hulthe, O Wiklund, E Hurt-Camejo, et al.
Journal of Internal Medicine|March 21, 2002
Carotid and femoral atherosclerosis, cardiovascular risk factors and C-reactive protein in relation to smokeless tobacco use or smoking in 58-year-old menK Wallenfeldt, J Hulthe, L Bokemark, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|July 10, 2008
Circulating oxidized LDL is associated with the occurrence of echolucent plaques in the carotid artery in 61-year-old menV Sigurdardottir, B Fagerberg, J Wikstrand, et al.
Clinical Science (London, England : 1979)|October 24, 2001
Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in womenA Dotevall, J Hulthe, A Rosengren, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Metabolism: Clinical and Experimental|February 15, 2001
Low-density lipoprotein particle size, insulin resistance, and proinsulin in a population sample of 58-year-old menB Fagerberg, J Hulthe, L Bokemark, et al.
Journal of Internal Medicine|October 16, 2004
Oxidized low-density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy menK Wallenfeldt, B Fagerberg, J Wikstrand, et al.
Atherosclerosis|December 31, 2005
apoB/apoA-I ratio is related to femoral artery plaques and is predictive for future cardiovascular events in healthy menC Schmidt, B Fagerberg, J Wikstrand, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 9, 2000
The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) studyJ Hulthe, L Bokemark, J Wikstrand, et al.
Journal of Internal Medicine|March 26, 2003
Multiple risk factor intervention reduces cardiovascular risk in hypertensive patients with echolucent plaques in the carotid arteryC Schmidt, B Fagerberg, J Wikstrand, et al.
Journal of Internal Medicine|May 15, 2001
Cell adhesion molecules and secretory type II phospholipase A2 in relation to carotid atherosclerosis in patients with hypercholesterolaemiaO Wiklund, J Hulthe, G Bondjers, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 7, 2001
Antibodies to oxidized LDL in relation to carotid atherosclerosis, cell adhesion molecules, and phospholipase A(2)J Hulthe, O Wiklund, E Hurt-Camejo, et al.
Journal of Internal Medicine|March 21, 2002
Carotid and femoral atherosclerosis, cardiovascular risk factors and C-reactive protein in relation to smokeless tobacco use or smoking in 58-year-old menK Wallenfeldt, J Hulthe, L Bokemark, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|July 10, 2008
Circulating oxidized LDL is associated with the occurrence of echolucent plaques in the carotid artery in 61-year-old menV Sigurdardottir, B Fagerberg, J Wikstrand, et al.
Clinical Science (London, England : 1979)|October 24, 2001
Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in womenA Dotevall, J Hulthe, A Rosengren, et al.
Pageof 4